4//SEC Filing
Chiniara Ellen 4
Accession 0000950170-25-002266
CIK 0001815442other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:00 PM ET
Size
5.5 KB
Accession
0000950170-25-002266
Insider Transaction Report
Form 4
Chiniara Ellen
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-01-06$41.75/sh−3,129$130,645→ 54,826 total
Footnotes (3)
- [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.50 to $41.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This number includes 1,203 shares and 792 shares acquired under the Registrant's employee stock purchase plan on June 1, 2024 and December 1, 2024, respectively.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001398764
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:00 PM ET
- Size
- 5.5 KB